FL S1816

Designates May 5-11, 2019, and the first full week in May each year thereafter as "Tardive Dyskinesia Awareness Week" in Florida.

Recognizes tardive dyskinesia as a condition causing involuntary muscle movements of the face, trunk, and extremities that can vary in frequency and severity.

Notes tardive dyskinesia may result from treatment with dopamine receptor blocking agents for psychiatric and nonpsychiatric conditions and may persist after treatment stops.

Identifies that more than 500,000 Americans taking antipsychotic medications may have tardive dyskinesia, with elderly, female, diabetic, and mentally ill populations at greater risk.